Immunomedics: Our Take On This Battleground Stock [Seeking Alpha]
IMMUNOMEDICS (IMMU)
Last immunomedics earnings: 2/27 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
immunomedics.com/2017/immunomedics-announces-presentations-investor-event-2017-san-antonio-breast-cancer-symposium
Company Research
Source: Seeking Alpha
Immunomedics: Our Take On This Battleground Stock Summary Today we take an in-depth look at Immunomedics, whose stock has been under pressure due to a complete response letter (CRL) regarding its primary drug candidate. The CRL was limited to manufacturing deficiencies. However, it will set the company back at least a year. Despite the delay, IMMU-132 has blockbuster potential with superior efficacy compared to standard-of-care remedies across many cancer indications. Recent management departures are troubling, but with a collaboration deal for Greater China and some recent insider buying, Immunomedics warranted a deeper dive. A full investment analysis follows in the paragraphs below. When people will not weed their own minds, they are apt to be overrun by nettles.” ? Horace Walpole Today, we look at a battleground stock in oncology. The last year for shareholders have read like a soap opera, with management turnover, an adverse FDA action as well as hope that the company will eventu
Show less
Read more
Impact Snapshot
Event Time:
IMMU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMMU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMMU alerts
High impacting IMMUNOMEDICS news events
Weekly update
A roundup of the hottest topics